Semax peptide guide for Reca. Research peptide with nootropic and neuroprotective properties — covers purity, COA testing, nasal vs injectable forms, and vendor evaluation.
Most researchers trying to source Semax in Reca rapidly learn that local retail options are essentially nonexistent. The key implication for Reca researchers: sourcing Semax comes down completely to vendor quality evaluation, not geography — and the evaluation methodology is the same regardless of where you are. Separating genuine research-grade Semax from the rest of the market requires three things: an HPLC chromatogram documenting ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. This guide gives Reca researchers the framework to evaluate Semax vendors systematically and source research-grade Semax with confidence.
Understanding Semax — Biology & Evidence
Semax belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in Reca studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
Semax Purchasing Guide
The first step for any Reca researcher sourcing Semax is identifying 2-3 vendors with documented positive community reputations — commercial rankings reflect SEO budgets rather than product quality. A COA for Semax should include: HPLC purity percentage with the underlying chromatogram, mass spectrometry data confirming the correct molecular weight, endotoxin test results, and a residual solvent panel — all specific to the lot you receive. Strong quality indicators beyond COA quality: established track record of at least two years, knowledgeable support capable of explaining COA data, and shipping with desiccant and appropriate cold protection. For Reca researchers making a first Semax purchase: verify the vendor against this framework, order conservatively at first, and confirm the COA batch number matches your received product before use.
Order Semax — ships to Reca
COA-verified · International tracking · Research grade
Research compound status for Semax means risk characterisation relies on animal studies, in-vitro work, and limited human observations — rather than the controlled trials that generate pharmaceutical safety profiles. Lyophilised Semax should be stored frozen (−20°C) immediately upon receipt; do not freeze and thaw reconstituted Semax multiple times by aliquoting into single-use portions. The primary quality-related safety risk in Semax research is endotoxin from inadequately tested product — a verified endotoxin panel in the batch COA is the direct mitigation for this hazard. PubMed are the primary literature resources for Semax research; focus on peer-reviewed publications with documented compound quality over unreviewed preprints or forum reports.
Frequently Asked Questions
How should Semax be stored?
Lyophilized Semax should be stored at −20°C. Once reconstituted or in liquid form, it should be kept refrigerated at 2-8°C and used within the vendor's specified timeframe (typically 4 weeks). Some researchers freeze Semax solution in individual use-aliquots to minimize repeated refrigeration exposure.
What purity should research Semax be?
Research-grade Semax should be ≥98% pure by HPLC. The COA should confirm the molecular weight of 887.0 Da by mass spectrometry. Due to the nasal mucosa sensitivity of the intranasal route, a low endotoxin level is particularly important to verify.
What does BDNF have to do with Semax?
BDNF (Brain-Derived Neurotrophic Factor) is a key regulator of neuroplasticity, neuronal survival, and synaptic strengthening. Animal model studies have documented that Semax administration upregulates BDNF expression in brain regions relevant to cognition and stress response. This BDNF upregulation is considered a primary mechanistic hypothesis for Semax's nootropic effects.
What is Semax?
Semax is a synthetic heptapeptide (MEHFPGP) derived from the ACTH4-7 fragment (Met-Glu-His-Phe) with a Pro-Gly-Pro C-terminal extension for stability. It has been studied for nootropic effects, BDNF upregulation, and neuroprotection in animal models. It has been used clinically in Russia for cognitive and neurological applications.
How is Semax administered in research?
The most studied administration route for Semax in both animal models and human research is intranasal. Intranasal delivery bypasses the blood-brain barrier via olfactory nerve transport. Subcutaneous injection is also used in animal studies. Intranasal Semax requires a specialized intranasal delivery device or dropper.
